Your browser doesn't support javascript.
loading
PTEN recruitment controls synaptic and cognitive function in Alzheimer's models.
Knafo, Shira; Sánchez-Puelles, Cristina; Palomer, Ernest; Delgado, Igotz; Draffin, Jonathan E; Mingo, Janire; Wahle, Tina; Kaleka, Kanwardeep; Mou, Liping; Pereda-Perez, Inmaculada; Klosi, Edvin; Faber, Erik B; Chapman, Heidi M; Lozano-Montes, Laura; Ortega-Molina, Ana; Ordóñez-Gutiérrez, Lara; Wandosell, Francisco; Viña, Jose; Dotti, Carlos G; Hall, Randy A; Pulido, Rafael; Gerges, Nashaat Z; Chan, Andrew M; Spaller, Mark R; Serrano, Manuel; Venero, César; Esteban, José A.
Afiliação
  • Knafo S; Department of Molecular Neurobiology, Centro de Biología Molecular "Severo Ochoa", Consejo Superior de Investigaciones Científicas (CSIC) / Universidad Autónoma de Madrid, Madrid, Spain.
  • Sánchez-Puelles C; Unidad de Biofísica CSIC-UPV/EHU, Campus Universidad del País Vasco, Leioa, Spain.
  • Palomer E; Ikerbasque, Basque Foundation for Science, Bilbao, Spain.
  • Delgado I; Department of Molecular Neurobiology, Centro de Biología Molecular "Severo Ochoa", Consejo Superior de Investigaciones Científicas (CSIC) / Universidad Autónoma de Madrid, Madrid, Spain.
  • Draffin JE; Department of Molecular Neurobiology, Centro de Biología Molecular "Severo Ochoa", Consejo Superior de Investigaciones Científicas (CSIC) / Universidad Autónoma de Madrid, Madrid, Spain.
  • Mingo J; Unidad de Biofísica CSIC-UPV/EHU, Campus Universidad del País Vasco, Leioa, Spain.
  • Wahle T; Department of Molecular Neurobiology, Centro de Biología Molecular "Severo Ochoa", Consejo Superior de Investigaciones Científicas (CSIC) / Universidad Autónoma de Madrid, Madrid, Spain.
  • Kaleka K; Biocruces Health Research Institute, Barakaldo, Spain.
  • Mou L; VIB Center for the Biology of Disease and Center for Human Genetics, University of Leuven (Katholieke University of Leuven), Leuven, Belgium.
  • Pereda-Perez I; IUF - Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany.
  • Klosi E; Department of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Faber EB; Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Chapman HM; Department of Psychobiology, Universidad Nacional de Educación a Distancia, Madrid, Spain.
  • Lozano-Montes L; Department of Pharmacology and Toxicology, Geisel School of Medicine at Dartmouth, and Norris Cotton Cancer Center, Lebanon, New Hampshire, USA.
  • Ortega-Molina A; Department of Pharmacology and Toxicology, Geisel School of Medicine at Dartmouth, and Norris Cotton Cancer Center, Lebanon, New Hampshire, USA.
  • Ordóñez-Gutiérrez L; Department of Pharmacology and Toxicology, Geisel School of Medicine at Dartmouth, and Norris Cotton Cancer Center, Lebanon, New Hampshire, USA.
  • Wandosell F; Department of Molecular Neurobiology, Centro de Biología Molecular "Severo Ochoa", Consejo Superior de Investigaciones Científicas (CSIC) / Universidad Autónoma de Madrid, Madrid, Spain.
  • Viña J; Tumor Suppression Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
  • Dotti CG; Department of Molecular Neurobiology, Centro de Biología Molecular "Severo Ochoa", Consejo Superior de Investigaciones Científicas (CSIC) / Universidad Autónoma de Madrid, Madrid, Spain.
  • Hall RA; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED).
  • Pulido R; Department of Molecular Neurobiology, Centro de Biología Molecular "Severo Ochoa", Consejo Superior de Investigaciones Científicas (CSIC) / Universidad Autónoma de Madrid, Madrid, Spain.
  • Gerges NZ; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED).
  • Chan AM; Department of Physiology, Faculty of Medicine, University of Valencia, Valencia, Spain.
  • Spaller MR; Department of Molecular Neurobiology, Centro de Biología Molecular "Severo Ochoa", Consejo Superior de Investigaciones Científicas (CSIC) / Universidad Autónoma de Madrid, Madrid, Spain.
  • Serrano M; Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Venero C; Ikerbasque, Basque Foundation for Science, Bilbao, Spain.
  • Esteban JA; Biocruces Health Research Institute, Barakaldo, Spain.
Nat Neurosci ; 19(3): 443-53, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26780512
ABSTRACT
Dyshomeostasis of amyloidpeptide (Aß) is responsible for synaptic malfunctions leading to cognitive deficits ranging from mild impairment to full-blown dementia in Alzheimer's disease. Aß appears to skew synaptic plasticity events toward depression. We found that inhibition of PTEN, a lipid phosphatase that is essential to long-term depression, rescued normal synaptic function and cognition in cellular and animal models of Alzheimer's disease. Conversely, transgenic mice that overexpressed PTEN displayed synaptic depression that mimicked and occluded Aß-induced depression. Mechanistically, Aß triggers a PDZ-dependent recruitment of PTEN into the postsynaptic compartment. Using a PTEN knock-in mouse lacking the PDZ motif, and a cell-permeable interfering peptide, we found that this mechanism is crucial for Aß-induced synaptic toxicity and cognitive dysfunction. Our results provide fundamental information on the molecular mechanisms of Aß-induced synaptic malfunction and may offer new mechanism-based therapeutic targets to counteract downstream Aß signaling.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Cognitivos / Transmissão Sináptica / PTEN Fosfo-Hidrolase / Doença de Alzheimer Limite: Animals Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Cognitivos / Transmissão Sináptica / PTEN Fosfo-Hidrolase / Doença de Alzheimer Limite: Animals Idioma: En Ano de publicação: 2016 Tipo de documento: Article